review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Borna Mehrad | Q41554549 |
P2093 | author name string | Robert M Strieter | |
Ellen C Keeley | |||
P2860 | cites work | Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling | Q22009382 |
Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides | Q24298587 | ||
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 | Q24303828 | ||
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis | Q24317603 | ||
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes | Q24336187 | ||
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 | ||
Delayed wound healing in CXCR2 knockout mice | Q24647498 | ||
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10 | Q24797335 | ||
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis | Q24804267 | ||
Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP) | Q28115465 | ||
Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung | Q74505936 | ||
Microvessel density in prostate cancer: prognostic and therapeutic utility | Q77312911 | ||
Regulation of Th1/Th2 development by antigen-presenting cells in vivo | Q77642268 | ||
Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization | Q77647010 | ||
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer | Q77948466 | ||
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action | Q78039757 | ||
Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium | Q78233810 | ||
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 | Q78701428 | ||
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis | Q78953015 | ||
Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy | Q79731289 | ||
Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells | Q80217129 | ||
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells | Q80396461 | ||
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A | Q80894668 | ||
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling | Q80901697 | ||
Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis | Q80937048 | ||
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells | Q82264553 | ||
Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines | Q82385171 | ||
Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis | Q46678597 | ||
Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome | Q46738032 | ||
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor | Q47816803 | ||
Angiogenic activity and interleukin-8 content of human ovarian cancer ascites | Q47925709 | ||
Chemokine/chemokine receptor nomenclature | Q48724450 | ||
Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. | Q51606009 | ||
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. | Q52563229 | ||
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. | Q53966284 | ||
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells | Q56890926 | ||
SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation | Q57838886 | ||
Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion | Q60495153 | ||
Time course of mitosis and collateral growth following coronary microembolization in the porcine heart | Q60495154 | ||
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 | Q61773870 | ||
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis | Q61942161 | ||
The interaction of platelet factor four and glycosaminoglycans | Q68936529 | ||
Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin | Q71612190 | ||
Tumor-associated angiogenesis in prostate cancer | Q71614828 | ||
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms | Q72350362 | ||
Interleukin-8 expression by head and neck squamous cell carcinoma | Q72495608 | ||
Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice | Q72523009 | ||
Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis | Q72844560 | ||
Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis | Q72998766 | ||
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization | Q73106062 | ||
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis | Q73160807 | ||
Factors regulating arteriogenesis | Q73217676 | ||
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint | Q73521731 | ||
IL-8 is an angiogenic factor in human coronary atherectomy tissue | Q73624327 | ||
Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma | Q73889192 | ||
Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis | Q73959004 | ||
Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells | Q73966728 | ||
Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice | Q74376048 | ||
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization | Q74477780 | ||
Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue | Q74500694 | ||
Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1 | Q28118847 | ||
Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer | Q28194900 | ||
Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins | Q28251702 | ||
The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules | Q28251856 | ||
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 | ||
Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress | Q28344704 | ||
Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia | Q28360935 | ||
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras | Q28511056 | ||
Tumor angiogenesis | Q29614938 | ||
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
Chemokines as mediators of angiogenesis. | Q30426904 | ||
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure | Q30611192 | ||
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity | Q33181330 | ||
Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. | Q33198267 | ||
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
Platelet factor 4: an inhibitor of angiogenesis | Q33361906 | ||
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
CXC chemokines in angiogenesis. | Q33983541 | ||
Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease | Q34134554 | ||
Lymphocyte traffic control by chemokines | Q34139610 | ||
Chemokines in cutaneous wound healing. | Q34224198 | ||
Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. | Q34349419 | ||
Vasculogenesis | Q34387300 | ||
Therapeutic angiogenesis and vasculogenesis for tissue regeneration | Q34404695 | ||
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice | Q34778647 | ||
Arteriogenesis: the development and growth of collateral arteries | Q35074935 | ||
Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. | Q35083426 | ||
Therapeutic angiogenesis in cardiovascular disease | Q35605439 | ||
How do chemokine/chemokine receptor activations affect tumorigenesis? | Q35694211 | ||
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. | Q35764209 | ||
Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. | Q35786830 | ||
Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells | Q35786924 | ||
Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair | Q35795557 | ||
Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. | Q35833621 | ||
Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats | Q35885920 | ||
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer | Q36009228 | ||
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 | Q36172008 | ||
Lung transplantation: opportunities for research and clinical advancement | Q36195432 | ||
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage | Q36204124 | ||
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer | Q36228506 | ||
Chemokines in myocardial ischemia. | Q36258323 | ||
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma | Q36363086 | ||
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases | Q36367319 | ||
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme | Q36481980 | ||
Post-ischaemic neovascularization and inflammation | Q37077934 | ||
The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan | Q37156706 | ||
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice | Q37356393 | ||
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer | Q37384020 | ||
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor | Q38310933 | ||
The pathogenesis of atherosclerosis: atherogenesis and inflammation | Q39631836 | ||
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity | Q39904117 | ||
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. | Q40118445 | ||
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis | Q40320652 | ||
The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth | Q40333696 | ||
Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping | Q40495285 | ||
Intussusceptive angiogenesis: its role in embryonic vascular network formation | Q40778004 | ||
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
Cxc chemokine receptor expression on human endothelial cells | Q40930195 | ||
Angiogenesis in ischemic heart disease | Q41338703 | ||
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms | Q41588972 | ||
Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression | Q41640097 | ||
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo | Q41732041 | ||
Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression | Q41895657 | ||
PRECAPILLARY SYSTEMIC-PULMONARY ANASTOMOSES. | Q42161084 | ||
CCL16 activates an angiogenic program in vascular endothelial cells. | Q42447162 | ||
Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells | Q42451021 | ||
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome | Q42727110 | ||
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases | Q43671920 | ||
Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway | Q44182908 | ||
Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. | Q45186058 | ||
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice | Q45862075 | ||
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis | Q46090369 | ||
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer | Q46374116 | ||
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma | Q46629337 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neovascularization | Q1281049 |
P304 | page(s) | 1928-1936 | |
P577 | publication date | 2008-08-28 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Chemokines as mediators of neovascularization | |
P478 | volume | 28 |
Q38787556 | Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy. |
Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
Q28082569 | Angiogenesis and liver fibrosis |
Q34475130 | Angiogenesis following cell injection is induced by an excess inflammatory response coordinated by bone marrow cells |
Q90325135 | Angiogenesis in the lung |
Q40881340 | Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation |
Q54646109 | Antiangiogenic agents and targets: A perspective |
Q35581401 | Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors |
Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
Q36284638 | Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis |
Q34528303 | Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs |
Q64941714 | CCR9:CCL25 in melanoma metastatic to small intestine. |
Q55257731 | CD11b+ interstitial macrophages are required for ischemia-induced lung angiogenesis. |
Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
Q35864800 | CXCL1 microspheres: a novel tool to stimulate arteriogenesis |
Q33708424 | CXCL5 is required for angiogenesis, but not structural adaptation after small bowel resection |
Q85218394 | CXCL8 enhances the angiogenic activity of umbilical cord blood-derived outgrowth endothelial cellsin vitro |
Q42653214 | CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells |
Q54704650 | CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β. |
Q34051762 | Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans |
Q35008659 | Characteristics of human Ewing/PNET sarcoma models |
Q62734904 | Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice |
Q26778691 | Chemokine Regulation of Angiogenesis During Wound Healing |
Q26778694 | Chemokine Regulation of Neutrophil Infiltration of Skin Wounds |
Q35179438 | Chemokines and BPH/LUTS |
Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
Q90401357 | Chemokines in Physiological and Pathological Bone Remodeling |
Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
Q83169012 | Chemokines in health and disease |
Q40221365 | Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure |
Q43201136 | Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro |
Q33517638 | Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases |
Q35162409 | Controlled protein delivery in the generation of microvascular networks. |
Q89951499 | Cxcr6-Based Mesenchymal Stem Cell Gene Therapy Potentiates Skin Regeneration in Murine Diabetic Wounds |
Q36187781 | Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion |
Q34518898 | Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease |
Q58119090 | Dengue Virus Potentially Promotes Migratory Responses on Endothelial Cells by Enhancing Pro-Migratory Soluble Factors and miRNAs |
Q43814712 | Determination of tear and serum inflammatory cytokines in patients with rosacea using multiplex bead technology. |
Q40842224 | Differential activity of pro-angiogenic CXC chemokines |
Q38366270 | Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines |
Q42771383 | Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27 |
Q37978259 | Disruption of embryonic vascular development in predictive toxicology |
Q51107995 | Early induction of NRF2 antioxidant pathway by RHBDF2 mediates rapid cutaneous wound healing. |
Q34081426 | Effects of ischemia on lung macrophages |
Q33970802 | Environmental impact on vascular development predicted by high-throughput screening |
Q42660944 | Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells |
Q33578550 | Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection |
Q39272972 | Expression of macrophage-derived chemokine (CCL22) in atherosclerosis and regulation by histamine via the H2 receptor |
Q33795730 | Extracellular matrix, inflammation, and the angiogenic response |
Q39670669 | Functional divergence between 2 chemokines is conferred by single amino acid change |
Q38764048 | Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo |
Q35626327 | Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization. |
Q38808589 | Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery |
Q54650117 | Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model |
Q37958925 | Inhibition of angiogenesis and the angiogenesis/invasion shift |
Q35994686 | Intermittent pneumatic leg compressions enhance muscle performance and blood flow in a model of peripheral arterial insufficiency |
Q82153760 | JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma |
Q35816474 | Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells |
Q92534720 | MMP12 Inhibits Corneal Neovascularization and Inflammation through Regulation of CCL2 |
Q34299710 | Macrophage cytokines: involvement in immunity and infectious diseases |
Q35041234 | Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury |
Q50423780 | Molecular Regulation of Sprouting Angiogenesis. |
Q52682224 | Monocyte chemoattractant protein 1 and fractalkine play opposite roles in angiogenesis via recruitment of different macrophage subtypes. |
Q34662234 | Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor |
Q30394158 | Multiplex cytokine levels of aqueous humor in acute primary angle-closure patients: fellow eye comparison |
Q35286823 | Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. |
Q52691329 | New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection. |
Q37518830 | Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone |
Q49918278 | PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells |
Q30431716 | Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease |
Q34825623 | Predictive integration of gene functional similarity and co-expression defines treatment response of endothelial progenitor cells |
Q34674982 | Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder |
Q64098308 | Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury |
Q35136727 | Reciprocal communication between endometrial stromal cells and macrophages |
Q59797572 | Relationship between CCL22 Expression by Vascular Smooth Muscle Cells and Macrophage Histamine Receptors in Atherosclerosis |
Q42264971 | Reproducible complete remission of advanced hepatocellular carcinoma with sorafenib in combination with clopidogrel |
Q28538588 | Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation |
Q27025680 | Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets |
Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
Q33592512 | The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells |
Q37970636 | The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines |
Q36098582 | The cutaneous vascular system in chronic skin inflammation |
Q35629760 | The effect of impaired angiogenesis on intestinal function following massive small bowel resection |
Q87460989 | The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor |
Q37394981 | The good and the bad of chemokines/chemokine receptors in melanoma |
Q34975382 | The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells |
Q35117974 | The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis |
Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
Q37863514 | The role of chemokines and their receptors in angiogenesis |
Q38129709 | The role of chemokines in acute and chronic hepatitis C infection |
Q92074720 | Three-Layered Silk Fibroin Tubular Scaffold for the Repair and Regeneration of Small Caliber Blood Vessels: From Design to in vivo Pilot Tests |
Q41892254 | Tumor-promoting circuits that regulate a cancer-related chemokine cluster: dominance of inflammatory mediators over oncogenic alterations |
Q35164593 | VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting |
Q30559386 | Vascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context. |
Search more.